Related Experiment Videos
Efficacy and safety of live recombinant BCG vaccines
M S Hanson1, G P Bansal, S Langermann
1Medimmune, Inc., Gaithersburg, MD, USA.
Developments in Biological Standardization
|January 1, 1995
Abstract:
BCG has a long history of safe use in humans and is one of the best adjuvants known. The use of newer production methods may further reduce the risk of adverse side-effects. Early results with experimental animals have shown BCG to be an effective live recombinant delivery vehicle for several foreign vaccine antigens. Additional refinements to the safety and efficacy of the recombinant BCG vaccine vehicle are under development.